Levisetti Matteo 4
4 · Cue Biopharma, Inc. · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-03-21+250,000→ 250,000 totalExercise: $0.99Exp: 2035-03-20→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025.